FDA Reclassifies Pelvic Mesh Devices As High-Risk, Orders Premarket Approval

(January 4, 2016, 1:30 PM EST) -- SILVER SPRING, Md. — The Food and Drug Administration on Jan. 4 issued final orders reclassifying pelvic mesh devices intended to treat pelvic organ prolapse (POP) from moderate-risk Class II to...
To view the full article, register now.